India · Delayed Price · Currency is INR Epigral Statistics
Total Valuation
Epigral has a market cap or net worth of INR 39.00 billion. The enterprise value is 44.63 billion.
| Market Cap | 39.00B |
| Enterprise Value | 44.63B |
Important Dates
The last earnings date was Monday, November 2, 2026.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
Epigral has 43.14 million shares outstanding. The number of shares has increased by 0.26% in one year.
| Current Share Class | 43.14M |
| Shares Outstanding | 43.14M |
| Shares Change (YoY) | +0.26% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 68.89% |
| Owned by Institutions (%) | 7.51% |
| Float | 13.40M |
Valuation Ratios
The trailing PE ratio is 13.69 and the forward PE ratio is 11.37.
| PE Ratio | 13.69 |
| Forward PE | 11.37 |
| PS Ratio | 1.40 |
| PB Ratio | 1.65 |
| P/TBV Ratio | 1.66 |
| P/FCF Ratio | 62.28 |
| P/OCF Ratio | 12.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.59, with an EV/FCF ratio of 71.27.
| EV / Earnings | 15.67 |
| EV / Sales | 1.60 |
| EV / EBITDA | 7.59 |
| EV / EBIT | 10.72 |
| EV / FCF | 71.27 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.35 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.97 |
| Debt / FCF | 9.11 |
| Interest Coverage | 21.40 |
Financial Efficiency
Return on equity (ROE) is 12.76% and return on invested capital (ROIC) is 10.76%.
| Return on Equity (ROE) | 12.76% |
| Return on Assets (ROA) | 7.62% |
| Return on Invested Capital (ROIC) | 10.76% |
| Return on Capital Employed (ROCE) | 14.48% |
| Weighted Average Cost of Capital (WACC) | 5.47% |
| Revenue Per Employee | 24.53M |
| Profits Per Employee | 2.51M |
| Employee Count | 1,135 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 5.05 |
Taxes
In the past 12 months, Epigral has paid 1.01 billion in taxes.
| Income Tax | 1.01B |
| Effective Tax Rate | 26.09% |
Stock Price Statistics
The stock price has decreased by -46.26% in the last 52 weeks. The beta is 0.30, so Epigral's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -46.26% |
| 50-Day Moving Average | 1,047.62 |
| 200-Day Moving Average | 1,069.44 |
| Relative Strength Index (RSI) | 41.60 |
| Average Volume (20 Days) | 59,540 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Epigral had revenue of INR 27.85 billion and earned 2.85 billion in profits. Earnings per share was 66.03.
| Revenue | 27.85B |
| Gross Profit | 9.94B |
| Operating Income | 4.16B |
| Pretax Income | 3.85B |
| Net Income | 2.85B |
| EBITDA | 5.79B |
| EBIT | 4.16B |
| Earnings Per Share (EPS) | 66.03 |
Balance Sheet
The company has 70.50 million in cash and 5.70 billion in debt, with a net cash position of -5.63 billion or -130.53 per share.
| Cash & Cash Equivalents | 70.50M |
| Total Debt | 5.70B |
| Net Cash | -5.63B |
| Net Cash Per Share | -130.53 |
| Equity (Book Value) | 23.65B |
| Book Value Per Share | 548.30 |
| Working Capital | 2.52B |
Cash Flow
In the last 12 months, operating cash flow was 3.09 billion and capital expenditures -2.46 billion, giving a free cash flow of 626.20 million.
| Operating Cash Flow | 3.09B |
| Capital Expenditures | -2.46B |
| Depreciation & Amortization | 1.63B |
| Net Borrowing | 261.30M |
| Free Cash Flow | 626.20M |
| FCF Per Share | 14.52 |
Margins
Gross margin is 35.68%, with operating and profit margins of 14.94% and 10.23%.
| Gross Margin | 35.68% |
| Operating Margin | 14.94% |
| Pretax Margin | 13.84% |
| Profit Margin | 10.23% |
| EBITDA Margin | 20.81% |
| EBIT Margin | 14.94% |
| FCF Margin | 2.25% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.55%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.55% |
| Dividend Growth (YoY) | -16.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 7.56% |
| FCF Payout Ratio | 34.45% |
| Buyback Yield | -0.26% |
| Shareholder Yield | 0.30% |
| Earnings Yield | 7.30% |
| FCF Yield | 1.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Epigral is 1,728.00, which is 91.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,728.00 |
| Price Target Difference | 91.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |